Plasma-derived human factor X concentrate for the treatment of patients with hereditary factor X deficiency.
Miguel A EscobarKaan KavakliPublished in: Haemophilia : the official journal of the World Federation of Hemophilia (2023)
Together, these studies support the use of pdFX for on-demand treatment of bleeding, routine prophylaxis, and perioperative management of bleeding in patients with HFXD.